首页> 外国专利> 5'-Phosphorothiolate mRNA 5'-end (cap) Analogs, mRNA Comprising the Same, Method of Obtaining and Uses Thereof

5'-Phosphorothiolate mRNA 5'-end (cap) Analogs, mRNA Comprising the Same, Method of Obtaining and Uses Thereof

机译:5′-硫代磷酸硫磷酸酯mRNA 5′-末端(帽)类似物,包含该类似物的mRNA,其获得方法和用途

摘要

The present invention relates to nucleotides, analogs of mRNA 5′-end (cap) containing sulfur atom at the position 5′ of 7-methylguanosine nucleoside. The disclosed compounds are recognized (bound and non-hydrolyzed) by DcpS enzyme (Decapping Scavenger), and thus may find therapeutic use as inhibitors thereof. DcpS is cap-specific enzyme with pyrophosphatase activity, which was identified as a therapeutic target in the treatment of spinal muscular atrophy (SMA). Some of the compounds disclosed have additional modifications in the phosphate chain, which modulate their affinity for DcpS enzyme. The present invention also relates to mRNAs modified at the 5′ end with mRNA 5′-end (cap) analogs containing 5′-phosphorothiolate moiety, which mRNAs have an increased stability and translational activity in cellular conditions, to a method of their preparation, their uses, and to a pharmaceutical formulation containing them, wherein L1 and L2 are independently selected from the group comprising O and S, wherein at least one of L1 and L2 is not O.; embedded image
机译:本发明涉及在7-甲基鸟苷核苷的5'位含有硫原子的mRNA 5'-末端(cap)类似物的核苷酸。所公开的化合物被DcpS酶(Decapping Scavenger)识别(结合和未水解),因此可以发现作为其抑制剂的治疗用途。 DcpS是具有焦磷酸酶活性的帽特异性酶,已被确定为治疗脊髓性肌萎缩症(SMA)的治疗靶标。公开的某些化合物在磷酸酯链中具有其他修饰,这调节了它们对DcpS酶的亲和力。本发明还涉及用含有5'-硫代磷酸酯部分的mRNA 5'-末端(cap)类似物在5'末端修饰的mRNA,该mRNA在细胞条件下具有增加的稳定性和翻译活性,涉及其制备方法,它们的用途以及包含它们的药物制剂,其中L 1 和L 2 独立地选自O和S,其中L 1 和L 2 不是O。 “嵌入式图像”

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号